Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC)

Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC)

Sixty-four SCLC patients (44 males and 20 females, median age 60 years, median PS 60%) were treated with an IEP regimen. Forty-nine cases were evaluable, 35 cases were limited disease (LD) and 14 cases were extensive disease (ED). Treatment consisted of ifosfamide 1.5 g/m2 i.v. infusion for 4 h on d...

Saved in:

書目詳細資料
Main Authors:	Thongprasert S., Jiamsriponges K.
格式:	Article
語言:	English
出版:	2014
在線閱讀:	http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3518
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer
由: Thongprasert S.
出版: (2014)

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer
由: Thongprasert S.
出版: (2014)

Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer
由: Chewaskulyong B., et al.
出版: (2014)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Charoentum C., et al.
出版: (2014)

Adoption of prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (ES-SCLC): A population based outcome study
由: Soon, Y.Y., et al.
出版: (2020)

Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer
由: Thongprasert S.
出版: (2014)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Chaiyut Charoentum, et al.
出版: (2018)

Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand
由: Unchalee Permsuwan, et al.
出版: (2020)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
由: Chitapanarux I., et al.
出版: (2014)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
由: I. Chitapanarux, et al.
出版: (2018)

Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital
由: Thongprasert S.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin
由: Gong X., et al.
出版: (2019)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
由: Chang J.W.-C., et al.
出版: (2014)

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
由: John Wen Cheng Chang, et al.
出版: (2018)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
由: Lehnert, M., et al.
出版: (2014)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
由: Lehnert, M., et al.
出版: (2016)

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

The socio-emotional competencies of children with ADHD in selected inclusive private schools in Metro Manila: Basis for IEP enrichment activities
由: Tanchingco, Esperanza C.
出版: (2017)

Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial
由: Mok T.S.K., et al.
出版: (2014)

Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial
由: Tony S K Mok, et al.
出版: (2018)

Comparison of Bladder Cancer Cells Apoptosis Induced by Metformin, Cisplatin, and Combination of Metformin-Cisplatin: In Vitro Study
由: Arifai Lumbangaol, et al.
出版: (2020)

OVERRIDING CISPLATIN RESISTANCE IN LUNG SQUAMOUS CELL CARCINOMA: INSIGHTS FROM COMBINATION WITH HDAC INHIBITOR
由: KONG LI REN
出版: (2014)

Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients
由: Sorraritchingchai S., et al.
出版: (2014)

Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital
由: Thongprasert S., et al.
出版: (2014)

Lung cancer and quality of life
由: Thongprasert S.
出版: (2014)

Graphene oxide nanoplatelets potentiate anticancer effect of cisplatin in human lung cancer cells
由: Nur Farhanah Rosli, et al.
出版: (2021)

Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE study
由: Keunchil Park, et al.
出版: (2018)

Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE study
由: Keunchil Park, et al.
出版: (2018)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Thongprasert S., et al.
出版: (2017)

Evaluation of Dose-Intense Ifosfamide, with and without Edatrexate, in Adults with Sarcoma
由: Casper, E. S., et al.
出版: (1999)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)